A Study to Evaluate INCB099280 in Participants With Advanced Cutaneous Squamous Cell Carcinoma
Status:
Not yet recruiting
Trial end date:
2026-12-31
Target enrollment:
Participant gender:
Summary
This study is being conducted to determine the safety, tolerability, and preliminary efficacy
of INCB099280 in participants with advanced Cutaneous Squamous Cell Carcinoma.